BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3066035)

  • 1. Hemodynamic consequences of supraventricular tachycardias and their antiarrhythmic treatment.
    Yusoff K; Tai YT; Campbell RW
    Z Kardiol; 1988; 77 Suppl 5():137-42. PubMed ID: 3066035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical viewpoints of hemodynamics in cardiac arrhythmias and during anti-arrhythmia treatment].
    Thormann J
    Z Kardiol; 1988; 77 Suppl 5():121-36. PubMed ID: 3066034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamics in ventricular arrhythmias and in their treatment].
    Lüderitz B; Manz M
    Z Kardiol; 1988; 77 Suppl 5():143-9. PubMed ID: 3066036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessory pathway reciprocating tachycardia.
    Obel OA; Camm AJ
    Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High frequency current catheter ablation in treatment of supraventricular and atrioventricular tachycardia].
    Hindricks G; Kottkamp H; Willems S; Chen X; Wichter T; Haverkamp W; Yli-Mäyry S; Breithardt G; Borggrefe M
    Z Kardiol; 1995; 84 Suppl 2():103-21. PubMed ID: 7571774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Supraventricular tachycardia due to simultaneous conduction in the rapid and slow nodal pathways. Treatment by ablation of the slow pathway].
    Goutner C; Dechandol AM; Bourguet JC; Donzeau JP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1651-5. PubMed ID: 8746002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatment of supraventricular tachycardia: drug therapy].
    Manz M; Lüderitz B
    Z Gesamte Inn Med; 1993 Sep; 48(9):430-8. PubMed ID: 8212748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Supraventricular tachycardias: mechanism, diagnosis and therapy].
    Osswald S; Buser PT; Rickenbacher P; Pfisterer M
    Schweiz Med Wochenschr; 1996 Jun; 126(22):974-85. PubMed ID: 8693318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regular supraventricular tachycardias associated with idiopathic atrial fibrillation.
    Gonzalez-Zuelgaray J; Perez A
    Am J Cardiol; 2006 Nov; 98(9):1242-4. PubMed ID: 17056338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience in 1,500 patients undergoing radiofrequency ablation in the treatment of tachycardias].
    Iturralde Torres P; Colín Lizalde L; Guevara Valdivia M; Rodríguez Chávez L; Kershenovich Shapiro S
    Arch Inst Cardiol Mex; 2000; 70(4):349-66. PubMed ID: 11075281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study.
    Chrysostomou C; Beerman L; Shiderly D; Berry D; Morell VO; Munoz R
    Anesth Analg; 2008 Nov; 107(5):1514-22. PubMed ID: 18931208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curing reentrant atrial arrhythmias. Targeting protected zones of slow conduction by catheter ablation.
    Lesh MD; Van Hare GF; Fitzpatrick AP; Griffin JC; Chu E
    J Electrocardiol; 1993; 26 Suppl():194-203. PubMed ID: 8189124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of supraventricular arrhythmias and atrial fibrillation.
    Shapira AR
    Am Fam Physician; 2009 Nov; 80(10):1089-94. PubMed ID: 19904893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
    Volkmann H; Kühnert H; Dannberg G; Küch N; Büttner A
    Z Gesamte Inn Med; 1989 Dec; 44(23):707-11. PubMed ID: 2629366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of changes in repolarization for the differential diagnosis of narrow QRS supraventricular tachycardia and the site of the accessory pathway].
    Fassini G; Riva S; Della Bella P; Carbucicchio C; Tondo C
    Cardiologia; 1996 Sep; 41(9):869-75. PubMed ID: 8983843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.